SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-06-05 11:47
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		O'Leary, James John
5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-553,744 vol 		0
Filed 2024-06-05 11:47
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		O'Leary, James John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition 		$-6,300
-300 vol
$21.00 each 		0
Filed 2024-06-05 11:41
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Leamon, Christopher Paul
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Units
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-63,700 vol 		0
Filed 2024-06-05 11:41
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Leamon, Christopher Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-574,100 vol 		0
Filed 2024-06-05 11:40
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Leamon, Christopher Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition 		$-251,097
-11,957 vol
$21.00 each 		0
Filed 2024-06-05 11:38
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Units
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-63,700 vol 		0
Filed 2024-06-05 11:38
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-232,268 vol 		0
Filed 2024-06-05 11:37
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-119,651 vol 		0
Filed 2024-06-05 11:37
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-955,544 vol 		0
Filed 2024-06-05 11:36
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Burak, Eric Steven
5 - Senior Officer of Issuer
Holder: Centre for Probe Development and Commercialization in trust for Eric Burak (Indirect Ownership)
Non-Voting Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-38,490 vol 		0
Filed 2024-06-05 11:33
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Bobilev, Dmitri
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Units
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-91,000 vol 		0
Filed 2024-06-05 11:33
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Bobilev, Dmitri
5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-701,700 vol 		0
Filed 2024-06-05 11:16
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
5 - Senior Officer of Issuer
Holder: Centre for Probe Development and Commercialization in trust for Valliant Consulting & Management Inc. (Indirect Ownership)
Voting Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-318,147 vol 		0
Filed 2024-06-05 11:15
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Units
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-192,200 vol 		0
Filed 2024-06-05 11:15
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-1,139,816 vol 		0
Filed 2024-06-05 11:14
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-443,828 vol 		0
Filed 2024-06-05 11:14
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-2,142,489 vol 		0
Filed 2024-06-05 11:09
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Units
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-81,300 vol 		0
Filed 2024-06-05 11:08
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-770,400 vol 		0
Filed 2024-06-05 11:08
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition 		$-269,703
-12,843 vol
$21.00 each 		0